P-335FOLFIRINOX versus Nab-paclitaxel plus gemcitabine in the first-line chemotherapy for patients with advanced pancreatic ductal adenocarcinoma: a multivariate analysis of prognostic factors in a national cohort (Comunica-TTD working group). (2nd July 2019) - Longo Muñoz, F; Castillo Trujillo, O; Serrano Domingo, J; Martín Huertas, R; Corral de la Fuente, E; San Juan, A; Portela, J; Cano, J; Reguera Puertas, P; Rodriguez Garrote, M; Izquierdo Manuel, M; Jimenez Fonseca, P; et al.